What Unites Congress? Scorn For Shkreli
Washington — A smirking Martin Shkreli briefly united Democrats and Republicans on Capitol Hill last week, as lawmakers took turns blasting the price-hiking former CEO who has become the new poster child for corporate greed. But the gridlocked state of Congress virtually assures federal efforts to lower drug prices will remain in limbo for years. And even then, experts warn that the options available to Congress would not stop...
Senate Probing Drug Price Spikes
Washington — A Senate committee has launched an investigation into exorbitant drug price hikes by Turing Pharmaceuticals and three other companies, responding to public anxiety over rising prices for critical medicines. The Senate’s special committee on aging requested documents and information Wednesday from Turing, Valeant Pharmaceuticals and two other drugmakers already under scrutiny for recent price spikes. Notably, the senators...
